MedPath

To study the efficacy of Yastimadhu Daruharidra Kwath Aschyotana and opticure eye drop in management of Sirotpat

Phase 3
Conditions
Health Condition 1: H102- Other acute conjunctivitis
Registration Number
CTRI/2022/02/040490
Lead Sponsor
Tilak Ayurveda Mahavidyalaya Pune
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patient suffering from Sirotpat having at least 3 classical symptoms of sirotpat

1. Redness

2. Sirajaladarshan

3. Daha (burning sensation)

4. Pain

Exclusion Criteria

1.Patient with episcleritis, corneal injury, corneal ulcer, keratitis, iridocyclitis

2.Immunocompromised patients

3. Patients with contagious diseases, malignancies

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the efficacy of Yastimadhu Daruharidra Kwath Aschyotana and opticure eye drop in the management of SirotpatTimepoint: <br/ ><br>7 to 10 days
Secondary Outcome Measures
NameTimeMethod
To compare the effect of yastimadhu daruharidra kwath aschyotana and opticure eye drop.Timepoint: 7to 10 days
© Copyright 2025. All Rights Reserved by MedPath